Yong‐Cheng Ma

Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents

Ying‐Chao Duan, Yong‐Cheng Ma, En Zhang et al. · European Journal of Medicinal Chemistry · 2013 · 263 citations

Pharmacy, Medicinal Chemistry, Oncology +12

Design and synthesis of tranylcypromine derivatives as novel LSD1/HDACs dual inhibitors for cancer treatment

Ying‐Chao Duan, Yong‐Cheng Ma, Wenping Qin et al. · European Journal of Medicinal Chemistry · 2017 · 85 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +8

Copper-catalyzed chalcogenation of imidazoheterocycles with sulfur/selenium powder and coumarinyl triflates

Tao Guo, Xu-Ning Wei, Hongyan Wang et al. · Organic & Biomolecular Chemistry · 2017 · 60 citations

Pharmacy, Medicinal Chemistry, Pharmacology +11

Jaridonin-induced G2/M phase arrest in human esophageal cancer cells is caused by reactive oxygen species-dependent Cdc2-tyr15 phosphorylation via ATM–Chk1/2–Cdc25C pathway

Yong‐Cheng Ma, Nan Su, Xiaojing Shi et al. · Toxicology and Applied Pharmacology · 2014 · 41 citations · Full text

Medicine, Cell Biology, Oncology +9

Jaridonin, a Novel Ent-Kaurene Diterpenoid from Isodon rubescens, Inducing Apoptosis via Production of Reactive Oxygen Species in Esophageal Cancer Cells

Yong‐Cheng Ma, Yu Ke, Xiaolin Zi et al. · Current Cancer Drug Targets · 2013 · 39 citations · Full text

Life Sciences, Medicinal Chemistry, Oncology +16